Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

Cerebrospinal fluid extracellular vesicle enrichment for protein biomarker discovery in neurological disease; multiple sclerosis.

Welton JL, Loveless S, Stone T, von Ruhland C, Robertson NP, Clayton A.

J Extracell Vesicles. 2017 Sep 3;6(1):1369805. doi: 10.1080/20013078.2017.1369805. eCollection 2017.

2.

A novel community driven software for functional enrichment analysis of extracellular vesicles data.

Pathan M, Keerthikumar S, Chisanga D, Alessandro R, Ang CS, Askenase P, Batagov AO, Benito-Martin A, Camussi G, Clayton A, Collino F, Di Vizio D, Falcon-Perez JM, Fonseca P, Fonseka P, Fontana S, Gho YS, Hendrix A, Hoen EN, Iraci N, Kastaniegaard K, Kislinger T, Kowal J, Kurochkin IV, Leonardi T, Liang Y, Llorente A, Lunavat TR, Maji S, Monteleone F, Øverbye A, Panaretakis T, Patel T, Peinado H, Pluchino S, Principe S, Ronquist G, Royo F, Sahoo S, Spinelli C, Stensballe A, Théry C, van Herwijnen MJC, Wauben M, Welton JL, Zhao K, Mathivanan S.

J Extracell Vesicles. 2017 May 26;6(1):1321455. doi: 10.1080/20013078.2017.1321455. eCollection 2017.

3.

Proteomics analysis of vesicles isolated from plasma and urine of prostate cancer patients using a multiplex, aptamer-based protein array.

Welton JL, Brennan P, Gurney M, Webber JP, Spary LK, Carton DG, Falcón-Pérez JM, Walton SP, Mason MD, Tabi Z, Clayton A.

J Extracell Vesicles. 2016 Jun 29;5:31209. doi: 10.3402/jev.v5.31209. eCollection 2016.

4.

Ready-made chromatography columns for extracellular vesicle isolation from plasma.

Welton JL, Webber JP, Botos LA, Jones M, Clayton A.

J Extracell Vesicles. 2015 Mar 26;4:27269. doi: 10.3402/jev.v4.27269. eCollection 2015.

5.

γδ T cells predict outcome in zoledronate-treated breast cancer patients.

Welton JL, Martí S, Mahdi MH, Boobier C, Barrett-Lee PJ, Eberl M.

Oncologist. 2013;18(8):e22-3. doi: 10.1634/theoncologist.2013-0097. No abstract available.

6.

Monocytes and γδ T cells control the acute-phase response to intravenous zoledronate: insights from a phase IV safety trial.

Welton JL, Morgan MP, Martí S, Stone MD, Moser B, Sewell AK, Turton J, Eberl M.

J Bone Miner Res. 2013 Mar;28(3):464-71. doi: 10.1002/jbmr.1797.

7.

In vivo evaluation of defined polished titanium surfaces to prevent soft tissue adhesion.

Hayes JS, Welton JL, Wieling R, Richards RG.

J Biomed Mater Res B Appl Biomater. 2012 Apr;100(3):611-7. doi: 10.1002/jbm.b.31967. Epub 2012 Jan 27.

PMID:
22282225
8.

Proteomics analysis of bladder cancer exosomes.

Welton JL, Khanna S, Giles PJ, Brennan P, Brewis IA, Staffurth J, Mason MD, Clayton A.

Mol Cell Proteomics. 2010 Jun;9(6):1324-38. doi: 10.1074/mcp.M000063-MCP201. Epub 2010 Mar 11.

9.

Interaction study between digoxin and a preparation of hawthorn (Crataegus oxyacantha).

Tankanow R, Tamer HR, Streetman DS, Smith SG, Welton JL, Annesley T, Aaronson KD, Bleske BE.

J Clin Pharmacol. 2003 Jun;43(6):637-42.

Supplemental Content

Loading ...
Support Center